Showing 541 - 560 results of 1,367 for search '(( significant decrease decrease ) OR ( significantly greater decrease ))~', query time: 0.24s Refine Results
  1. 541
  2. 542

    Descriptive statistics. by Yintu Bao (12113769)

    Published 2025
    “…The analysis reveals that the SHRR program significantly reduces travel frequency, likely due to improved local accessibility that decreases the need for frequent trips. …”
  3. 543

    Variable description. by Yintu Bao (12113769)

    Published 2025
    “…The analysis reveals that the SHRR program significantly reduces travel frequency, likely due to improved local accessibility that decreases the need for frequent trips. …”
  4. 544

    Village characteristics. by Yintu Bao (12113769)

    Published 2025
    “…The analysis reveals that the SHRR program significantly reduces travel frequency, likely due to improved local accessibility that decreases the need for frequent trips. …”
  5. 545

    Research data 2. by Yintu Bao (12113769)

    Published 2025
    “…The analysis reveals that the SHRR program significantly reduces travel frequency, likely due to improved local accessibility that decreases the need for frequent trips. …”
  6. 546
  7. 547
  8. 548
  9. 549
  10. 550
  11. 551
  12. 552
  13. 553
  14. 554

    Summary of study eligibility criteria. by Biban Gill (1473337)

    Published 2025
    “…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”
  15. 555

    Summary of study participation and feasibility. by Biban Gill (1473337)

    Published 2025
    “…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”
  16. 556

    Package alternatives for deli meat. by Monireh Mahmoudi (21989413)

    Published 2025
    “…<div><p>Consumer food waste remains a significant concern in the United States, where approximately 40% of food goes uneaten, leading to major economic and environmental consequences. …”
  17. 557

    The study timeline. by Monireh Mahmoudi (21989413)

    Published 2025
    “…<div><p>Consumer food waste remains a significant concern in the United States, where approximately 40% of food goes uneaten, leading to major economic and environmental consequences. …”
  18. 558
  19. 559
  20. 560

    Results of the LMM analysis for IOP change. by Sayaka Kimura-Uchida (22793666)

    Published 2025
    “…The preoperative IOP was 15.06 ± 3.51 mmHg and significantly reduced to 12.22 ± 2.23 mmHg at 3 months and 12.99 ± 2.45 mmHg at 12 months. …”